× ×ª×× × ×ª×¨×פ×
××רש×
| ק×××¦× ×¤×¨×ק×××××ת (ATC4)
|
L01XE
Protein kinase inhibitors
|
| ×ר××× ×¤×¢×× (ATC5)
|
Â
|
| צ×רת ×ת×
|
פ××× - PER OS
|
| צ×רת ××× ××
|
קפס×××ת ר××ת, CAPSULES SOFT
××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר××
|
| ×ת××××
|
Acute myeloid leukaemia (AML)Â :Rydapt is indicated in combination with standard induction and consolidation chemotherapy followed by single-agent maintenance therapy for adults with newly diagnosed acute myeloid leukaemia (AML) who have an FLT3 mutation.Advanced systemic mastocytosis (advanced SM)Â :Rydapt is indicated for the treatment of adult patients with advanced systemic mastocytosis (advanced SM).
|
| × ×ª×× × ×ס×
|
ת×ר×× ××××× ×ס×
- 11/01/2018
|
×××××ת ×ס×
- תר××¤× ×××××ת ×ר×ש×× ×¢'× ×¨××¤× ××××× ×× ××××× ××רת
|
×ת×××× ×ס×
| ×ת×××× |
ת×ר×× ××××× |
ת××× ×§××× × |
Class Effect |
××¦× ×××× |
×ס×ס ×××××ת
|
| ×. ×תר××¤× ×ª×× ×ª× ×××פ×× ××××× ×××ר ×¢× ×ס××צ×××××ס ס×ס×××ת ×תק××ת (advanced systemic mastocytosis). ×ת×ש×ר ×× ××× ×ª× ×ש×××× ×¢× Avapritinib. ×. ××ª× ×תר××¤× ×××××¨× ×××¢×©× ××¤× ××¨×©× ×©× ×¨××¤× ××××× ×××× ×§×××××× ×× ×¨××¤× ××××× ××××××××××.
|
17/03/2024 |
××××××××× |
|
Systemic mastocytosis |
|
| ×. ×תר××¤× ×ª×× ×ª× ×××פ×× ××××× ×××ר ×¢× ×ס××צ×××××ס ס×ס×××ת ×תק××ת (advanced systemic mastocytosis). ×. ××ª× ×תר××¤× ×××××¨× ×××¢×©× ××¤× ××¨×©× ×©× ×¨××¤× ××××× ×××× ×§×××××× ×× ×¨××¤× ××××× ××××××××××.
|
11/01/2018 |
××××××××× |
|
Systemic Mastocytosis |
|
| ×. ×תר××¤× ×ª×× ×ª× ×××פ×× ×××ק××× ×ס×× AML (Acute myeloid leukemia) ××××× ×××ר ×¢× ×××צ×× ×ס×× FLT3, ש××¨× ×§××× ××פ×× ××××ת×. ×××פ×× ××× ×ª× ×ש×××× ×¢× ××××תרפ×× ×¡×× ×ר××ת ×ש××× ×××× ××קצ×× ××ק×× ×¡××××צ×× ××××× ×תרפ×× ×ש×× ××××ק×. ×. ××ª× ×תר××¤× ×××××¨× ×××¢×©× ××¤× ××¨×©× ×©× ×¨××¤× ××××× ×××× ×§×××××× ×× ×¨××¤× ××××× ××××××××××.
|
11/01/2018 |
××××××××× |
|
FLT3+ AML |
|
|
ש×××ש ×ס×
-
|
×ס×רת ××××× ×ס×
- ×. ×תר××¤× ×ª×× ×ª× ×××פ×× ××קר×× ××××:
- 1. ××ק××× ×ס×× AML (Acute myeloid leukemia) ××××× ×××ר ×¢× ×××צ×× ×ס×× FLT3, ש××¨× ×§××× ××פ×× ××××ת×. ×××פ×× ××× ×ª× ×ש×××× ×¢× ××××תרפ×× ×¡×× ×ר××ת ×ש××× ×××× ××קצ×× ××ק×× ×¡××××צ×× ××××× ×תרפ×× ×ש×× ××××ק×.
- 2. ×××× ×××ר ×¢× ×ס××צ×××××ס ס×ס×××ת ×תק××ת (advanced systemic mastocytosis).
- ×. ××ª× ×תר××¤× ×××××¨× ×××¢×©× ××¤× ××¨×©× ×©× ×¨××¤× ××××× ×××× ×§×××××× ×× ××××× ××××××××××.
|
|
| ×¢××× ×ר××¤× ××××ר×ת ××¢×××
|
Â
Â
|
| ××פ×ש ×××ר××
|
×××ר×× ×-PubMed
|
| ××××¢ ×רשת
|
RxList WebMD Drugs.com
|
| ×©× ×צר×
|
CATALENT GERMANY EBERBACH GMBH, GERMANY
|
| ×©× ××¢× ×ר×ש××
|
NOVARTIS ISRAEL LTD
|
| ר×ש×××
|
ת×ר×× ××ש×: 7/2017. ר×ש××× ×ת×ר××:
|
| ת×ר×× ×¢×××× ××ר××
|
{{{ת×ר×× ×¢××××}}}
|
ת××× ×ª ×ר×××
ת×ר×× ×¢××××: {{{ת×ר×× ×¢××××}}}
CATALENT
ר××××¤× - Rydapt
true
השינוי האחרון נעשה בֹ־7 באפריל 2023 ב־10:07
